CELLO HEALTH ENHANCES WEST COAST US PRESENCE

Cello Health welcomes James Hyde-Dunn, PhD, Vice President, Business Development to the West Coast US team.  He is responsible for identifying opportunities by which our clients will benefit from the fusion of expertise across our best-in-class Communications, Insight, and Consulting capabilities. 

James’ broad and deep experience aligns well with these core capabilities in Cello Health.  He has worked in the San Francisco Bay area for over a decade with roles in brand management, market research and scientific communications on both the client and agency sides. He has held clinical and publication roles in Gilead and Genentech.  Most recently, James led a client service team for a market research company, and prior to that presided over the San Francisco operation for the Brand Institute.

The addition of James represents Cello Health’s commitment to expanding our capacity on the West Coast to optimize support with biopharmaceutical clients.  He will work from the organization’s Burlingame office, home of Promedica, the market research firm acquired in December, and will collaborate closely with leadership to tightly coordinate business development activities across the Cello Health family. 

“We are delighted to welcome James to our team as we continue our West Coast expansion.  His experience set is an excellent match to Cello Health’s capabilities and we are confident he will be able to help clients unlock the potential of their assets or organizations through the right blend of expertise within our organization,” said Julia Ralston, CEO of Cello Health US.